Annual Report 2021
- Index
- Search
No search results. Please enter a different search term.
Consolidated statement of cash flows
in thousand EUR | Notes | 2021 | 2020 | |||
---|---|---|---|---|---|---|
Net cash flow from operating activities | ||||||
Profit/(loss) for the period | 4 686 | –2 181 | ||||
Income taxes (income)/expenses | 28 | 3 263 | 1 111 | |||
Interest income | –29 | –0 | ||||
Interest expenses | 9 | 2 449 | 2 747 | |||
Dividend income from non-current assets | 9 | – | –119 | |||
Profit/(loss) for the period before interest and tax | 10 369 | 1 558 | ||||
Depreciation, amortization and impairment | 8 | 4 329 | 3 882 | |||
(Profit)/loss on sale of non-current assets | –202 | 62 | ||||
Gain recognized on contribution of net assets into associate | 7 | – | –1 368 | |||
Share of (profit)/loss of associates | 13 | 723 | 354 | |||
Gain recognized on FV measurement on previously held interest in an associate | –110 | – | ||||
Disposal of financial liabilities as a result of forgiveness | 19 | –400 | – | |||
Changes in provisions | 185 | 186 | ||||
Increase obsolence reserve on inventories | 15 | 624 | 900 | |||
Change in fair value of biological assets | 11 | –4 074 | –927 | |||
Other non-cash items | 13 | –87 | ||||
Operating cash flow before working capital changes | 11 457 | 4 560 | ||||
Decrease/(increase) in trade and other receivables | 17 | –1 213 | –5 973 | |||
Decrease/(increase) in inventories | 15 | –3 887 | –382 | |||
Decrease/(increase) in prepayments and assets held for sale | 56 | 824 | ||||
Increase/(decrease) in trade payables and other liabilities | 18 | 1 174 | 7 112 | |||
Income tax (paid)/received | 28 | –1 538 | –273 | |||
Net cash flow operating activities | 6 049 | 5 868 | ||||
Cash flow from investing activities | ||||||
Proceeds from sale of intangible assets | 12 | 1 471 | 1 | |||
Purchase of intangible assets | 12 | –1 366 | –125 | |||
Proceeds from sale of property, plant and equipment | 10 | 15 | 33 | |||
Purchase of property, plant and equipment | 10 | –1 604 | –3 994 | |||
Acquisition of subsidiaries, net of cash | 32 | –553 | – | |||
Issuance of financial assets to associates | – | –291 | ||||
Proceeds from disposal of other non-current assets | – | 342 | ||||
Purchase of other non-current assets | –311 | –260 | ||||
Increase/(decrease) in recoverable taxes | –13 | – | ||||
Dividends from associates | 13 | – | 138 | |||
Dividends from non-current financial assets | 9 | – | 119 | |||
Interests received | 29 | 0 | ||||
Net cash flow investing activities | –2 332 | –4 038 | ||||
Cash flow from financing activities | ||||||
Proceeds from borrowings | 19 | 904 | 2 141 | |||
Repayment of borrowings | 19 | –3 535 | –1 270 | |||
Interests paid | 19 | –1 245 | –1 492 | |||
Interests paid on lease liabilities | 19 / 21 | –142 | –127 | |||
Repayment of lease liabilities | 19 / 21 | –273 | –815 | |||
Net cash flow financing activities | –4 291 | –1 563 | ||||
Net increase/(decrease) in cash and cash equivalents | –574 | 267 | ||||
Cash and cash equivalents, at the beginning of the year | 2 778 | 2 578 | ||||
Increase/(decrease) in cash and cash equivalents | –574 | 267 | ||||
Translation effect on cash | 52 | –67 | ||||
Total Cash and cash equivalents, at the end of the year | 2 256 | 2 778 |